Teva Pharmaceutical Industries Ltd. Logo

Teva Pharmaceutical Industries Ltd.

A biopharmaceutical firm that develops and markets generic and specialty medicines.

TEVA | TA

Overview

Corporate Details

ISIN(s):
US8816242098 (+1 more)
LEI:
549300BAFGM4RC74ZJ94
Country:
Israel
Address:
124 DVORA HANEVIA, 6944020 TEL AVIV

Description

Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical company that develops, produces, and markets a broad portfolio of medicines. The company's business is centered on two main segments: generic medicines and innovative specialty treatments. As one of the world's largest manufacturers of generic drugs, Teva provides a wide range of affordable products across numerous therapeutic areas. Its specialty and biopharmaceutical research focuses on developing novel treatments, with a significant emphasis on central nervous system (CNS) disorders, including therapies for schizophrenia, tardive dyskinesia, and bipolar disorder. The company's portfolio also includes complex generics, biosimilars, and active pharmaceutical ingredients (APIs), while leveraging advanced technologies to enhance drug development and manufacturing.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-05 22:07
10-Q
English 2.2 MB
2025-11-05 17:49 English 11.3 KB
2025-11-05 15:10
Reports 2025 Third Quarter Financial Results
English 746.2 KB
2025-11-05 15:10
Reports 2025 Third Quarter Financial Results
English 36.5 KB
2025-11-05 13:00
FORM 8-K
English 198.4 KB
2025-10-06 12:08 English 9.1 KB
2025-09-12 22:05 English 7.8 KB
2025-09-10 01:11
Immediate Report
English 335.4 KB
2025-09-10 01:11
Immediate Report
English 36.3 KB
2025-09-09 22:02
4
English 6.8 KB
2025-08-06 18:14 English 11.3 KB
2025-08-06 01:14
Immediate Report
English 338.5 KB
2025-08-06 01:14
Immediate Report
English 36.3 KB
2025-08-06 01:13
Immediate Report
English 340.1 KB
2025-08-06 01:13
Immediate Report
English 36.3 KB

Automate Your Workflow. Get a real-time feed of all Teva Pharmaceutical Industries Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Teva Pharmaceutical Industries Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Teva Pharmaceutical Industries Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.